A trial to evaluate the three year efficacy and safety of denosumab on Bone Mineral Density and bone microarchitecture, in women with postmeno- pausal osteoporosis
Latest Information Update: 16 May 2016
At a glance
- Drugs Denosumab (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 16 May 2016 New trial record
- 17 Apr 2016 Results presented at the 2016 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases